What is MGRX's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 0.01B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for MGRX?

P/E (TTM) is n/a and 52-week range is $0.16 to $2.50 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s MGRX figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for MGRX?

The company profile lists revenue (TTM) near $409K, net income (TTM) near -$1.96B, EPS (TTM) near -$1.14 when available from the market-data feed. Figures are informational and may lag live markets.

Where is Mangoceuticals Inc based, and what identifiers does Chartloom list?

The company context section lists headquarters in Dallas, Texas, US, 22.2M shares outstanding, ISIN US56270V2051 when available from company profile and filing metadata.

Please enable JavaScript to continue using this application.

Mangoceuticals Inc

$MGRX

Consumer Staples · Consumer Staples Distribution & Retail

IR Run Scenarios

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

Mangoceuticals, Inc. engages in developing, marketing, and selling men's wellness products and services via a telemedicine platform. The company is headquartered in Dallas, Texas. The company went IPO on 2023-03-21. The company is advancing its proprietary antiviral compound MGX-0024. The firm offers pharmaceutical-based products specifically related to the treatments of erectile dysfunction (ED), hair growth, hormone replacement therapies, and weight management. The company has developed and is commercially marketing a brand of ED products under the brand name Mango; a brand of hair loss products under the brand name Grow; a brand of hormone balance and therapy products under the name Mojo, and a brand of weight loss products under the brand name Slim. Prime by MangoRx is a TRT product available by prescription. The Mango ED product includes the three ingredients: Either Sildenafil (the active ingredient in Viagra) or Tadalafil (the active ingredient in Cialis), and Oxytocin.

Website

www.mangorx.com/

IPO

2023-03-21

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)

Net income (TTM)

EPS (TTM)